Last updated on August 5th, 2022 at 11:33 am
The challenge of innovating in healthcare
Why do we need innovation in healthcare? As the world continues to age, its population is becoming increasingly elderly. The world population has increased by 2 billion since 1990, with implications for nearly every sector of society.
Healthcare innovations are becoming increasingly important for improving patient care and reducing costs. In fact, the U.S. spends twice as much on healthcare per capita as any other nation but still ranks only 17th in quality of care.
Innovation can be defined as invention + adoption + diffusion. In healthcare, it may be a novel idea, product, service, or care pathway that has clear benefits when compared to what is currently done.
Worldwide, high blood pressure (hypertension) is one of the biggest causes of heart attacks and strokes and the leading risk factor for 10 million deaths each year. With a predicted rise of 500 million cases by 2025, prevalence is currently estimated at about 1.5 billion globally. Accurate, reliable, and repeated blood pressure readings are critical for diagnosing hypertension. Out-of-office blood pressures can help identify patients who would benefit from further evaluation and treatment.
Hypertension affects approximately one billion people worldwide, according to the WHO. The World Health Organisation estimates that 1.13 Bn people worldwide have hypertension.
Successful innovations often possess two key qualities: they are both usable and desirable. How can proven innovations be quickly and effectively adopted as best practices and taken up across the whole healthcare system?
Innovation In Healthcare
Healthcare has benefited greatly from recent technological advances.
Health care technology is constantly evolving, but perhaps not quite as quickly as we might wish.
Healthcare professionals can now communicate with their patients using mobile phones, emails, telemonitoring, telemedicine systems, etc., which are particularly useful when providing care in remote areas where there are shortages of specialists and facilities.
Two-way video consultation or healthcare data transmission is an extremely useful technology tool for the purposes of telehealth and telemedicine to help patients who may not be able to visit their doctors due to distance or time constraints.
Healthcare Technology is changing fast, but maybe not as quickly as we would hope.
Information and communication technology (ICT) has created an exciting opportunity to link healthcare professionals to their patients like never before. In order to share information, the healthcare industry now makes extensive use of smartphones, email, telemonitoring, and telemedicine systems. These technologies are particularly useful while delivering healthcare in rural areas suffering due to the lack of specialists and facilities.
Telehealth and telemedicine are extremely useful technology tools for the purpose of two-way video consultations or healthcare data transmission. Telemedicine has already proven its utility in many fields such as cardiovascular healthcare.
Current situation and the future (Telemedicine Solutions)
Blood pressure measurement and mobile health diagnostics have been shown to be effective and scalable for chronic disease detection and management. By maximizing the smartphone’s optics and computational power, they could allow the assessment of physiological information from the morphology of pulse waves and thus estimate cuffless blood pressure (BP).
With its patented OptiBP technology, Biospectal provides accurate blood pressure measurements and management at the point of care—in less than 10 seconds.
High blood pressure (BP) remains the leading risk factor for death and disability in both high and low-income countries. Its complications are responsible for the deaths of approximately ten million people annually, a 50% increase over the estimates from 1990. By 2025, the number of people suffering from hypertension will reach 1.5 billion. The impact of this disease represents a daunting burden to any healthcare system.
Digital health approaches, and in particular mobile health (mHealth) diagnostics, have been shown to be effective, scalable, and sustainable for chronic disease prevention and management. Mobile phones represent a widespread, readily available device for mHealth. Worldwide, over one-third of consumers own a mobile phone.
If the accuracy of reliable smartphone-based blood pressure measurements was to be demonstrated, this would be a promising tool that could improve access to more populations, medical record-keeping, analysis of blood pressure measurements for hypertension management as well as medication compliance and health education.
How Biospectal OptiBP works
The Biospectal OptiBP app runs on a typical smartphone and uses the built-in camera to record a user’s blood flow via their fingertip quickly and easily. A measurement is rendered in approximately 20 seconds half the time of a typical blood pressure cuff.
Biospectal’s proprietary algorithms and optical signal capture methods then transform the captured data into blood pressure values. Additionally, the captured blood pressure data connects seamlessly with a user’s clinicians to support treatment regimens that help improve health, longevity, and quality of life.
Innovation In Healthcare: Wearable Technologies benefits include
- Connected remote patient monitoring shortens the pathway from measurement to action in a clinical regimen;
- Easy to use with an existing, ubiquitous device the smartphone removes adherence barriers;
- Allows users to measure and monitor their blood pressure in their ‘natural’ environment, which is where blood pressure should be monitored;
- App form factor offers continuous product improvement and feature updates; and
- Unprecedented data insights drive higher value for drug development and lower insurance costs.
No other blood pressure monitoring and management device on the market offers both the medical-grade accuracy and convenience of Biospectal.
Blood pressure measurement – OptiBp for iOS
The Biospectal OptiBP for iOS alpha is available now in the US, UK, France, Germany, Spain, and Switzerland. Interested participants can register for the alpha here or sign up to be notified once Biospectal OptiBP becomes available in their country.
Sources & Credits: